Strides acquires FDA-approved facility in US
Bengaluru-headquartered Strides Pharma Science Limited on Tuesday announced that its step down subsidiary Strides Pharma Inc (SPI) has acquired a USFDA-approved manufacturing facility in Florida, USA, from Micelle BioPharma Inc.
Bengaluru: Bengaluru-headquartered Strides Pharma Science Limited on Tuesday announced that its step down subsidiary Strides Pharma Inc (SPI) has acquired a USFDA-approved manufacturing facility in Florida, USA, from Micelle BioPharma Inc.
Micelle's facility is based in Riviera Beach, Florida, and is one of the very few manufacturing facilities in the US with a softgel capsule (SGC) manufacturing suite for formulations with containment needs, Strides said.
Next Story
Woman injured in stabbing attack in Tokyo, suspect at large
Bengal cop booked for murder over mysterious death of woman home guard, SIT to probe case
Staffer recalls horror of 7-kg gold robbery by armed gang in Karnataka’s Hunsur
25-Year-Old Airline Cabin Crew Member Dies At Gurugram Party; Police Begin Investigation
